Vera Therapeutics, Inc. (VERA)
34.19
-0.41
(-1.18%)
USD |
NASDAQ |
Aug 28, 16:00
34.22
+0.03
(+0.09%)
After-Hours: 20:00
Vera Therapeutics Shareholders Equity (Quarterly) : 407.76M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 407.76M |
| March 31, 2026 | 499.70M |
| December 31, 2025 | 604.52M |
| September 30, 2025 | 398.88M |
| June 30, 2025 | 468.28M |
| March 31, 2025 | 535.00M |
| December 31, 2024 | 577.16M |
| September 30, 2024 | 289.06M |
| June 30, 2024 | 327.87M |
| March 31, 2024 | 353.54M |
| December 31, 2023 | 101.68M |
| September 30, 2023 | 123.71M |
| Date | Value |
|---|---|
| June 30, 2023 | 140.52M |
| March 31, 2023 | 157.71M |
| December 31, 2022 | 76.91M |
| September 30, 2022 | 105.72M |
| June 30, 2022 | 121.50M |
| March 31, 2022 | 134.42M |
| December 31, 2021 | 69.59M |
| September 30, 2021 | 85.48M |
| June 30, 2021 | 92.16M |
| March 31, 2021 | 46.26M |
| December 31, 2020 | 50.23M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 532.98M |
| Total Liabilities (Quarterly) | 125.23M |
| Debt to Equity Ratio | 0.1845 |
| Current Ratio | 10.65 |
| Net Debt Paydown Yield | -0.13% |